Assessment of the Impact of Systemic Chemotherapy on the Quality of Life (QOL) in Patients with Metastatic Appendiceal Epithelial Neoplasms (AEN)
The goal of this research study is to learn if systemic chemotherapy including 5-fluorouracil can help to improve the quality of life in patients with cancer of the appendix that has spread to the abdomen.
Treatment Location: N/A
PRIMARY OBJECTIVE: 1. Determine if systemic chemotherapy will improve the quality of life (QOL) in appendiceal epithelial neoplasms (AEN) patients who are not candidates for surgical debulking following 6 months of chemotherapy versus baseline.
IRB Review and Approval Date: 06/16/2008
Recruitment Status: Closed
Projected Accrual: N/A
Phone Number: 800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
clinicaltrials.gov NCT No: Not Applicable Clinical Trial
Information and next steps
Gastrointestinal Medical Oncology
For general questions about clinical trials: